Indigenously Developed 'Covaxin' Gets Nod From Expert Panel

An expert panel of the Central Drugs Standards Control Organisation (CDSCO) has recommended the restricted emergency-use of the indigenously developed COVID-19 vaccine - 'Covaxin'. It got the panel’s nod a day after Oxford’s 'Covishield' secured approval. Developed by Bharat Biotech, 'Covaxin' now awaits the final approval from the Drug Controller General of India (DCGI). Bharat Biotech had earlier stated that ‘Covaxin’ would be effective against the new COVID-19 strain as well.